Chiropractors in Sanibel, FL Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Jaclyn Elizabeth Walsh, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1456 Periwinkle Way, Suite C, Sanibel, FL 33957 Phone: 270-519-5665 |
 Dr. Joseph Michael Tolisano, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1456 Periwinkle Way, Suite C, Sanibel, FL 33957 Phone: 239-472-0900 Fax: 239-472-1968 |
News Archive
South Dakota researchers aim to improve tobacco-free policies in health-care facilities
Health-care facilities being tobacco-free seems like a natural fit, but it's far more complicated than it might seem.
Creating a value development plan should be at the forefront of biopharmaceutical market
Mitch DeKoven, Director, HEOR, Real-World Evidence Solutions, IMS Health Inc. and Won Chan Lee, Ph.D., Principal, Health Economics and Outcomes Research, IMS Health, Inc. will present Optimizing Strategic Direction with Systematic Value Development at the Pharmaceutical Market Access Pricing and Reimbursement Conference in San Francisco on October 29, 2013.
UnitedHealth plan to boost dividends may draw criticism
The Associated Press: UnitedHealth Group has drastically raised dividends paid to shareholders - from $35 million to $560 million a year - in a move that may draw criticism for profits that rose alongside soaring health costs. "There is somewhat of a risk, especially in the current fragile reform environment, that says, 'Why is UnitedHealth declaring a dividend instead of lowering health care costs for its members?'" said analyst Tom Carroll.
Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.
National Alzheimer's plan to include more research funding
The Obama administration wants to spend just over half a billion dollars on Alzheimer's research next year, hoping to battle back against what could become the defining disease of the aging baby-boom generation. ... The move is part of the administration's development of the first National Alzheimer's Plan, a congressionally-ordered strategy that will combine research toward better dementia treatments with steps to help overwhelmed families to better cope today.
› Verified 3 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists